Vaccitech Plc. has placed 6 500 000 American Depositary shares(ADSs) in an IPO priced $17 per share, which corresponds to the midpoint of the previously announced range ($16-18). Besides, Vaccitech has granted the underwriters a 30-day option to purchase up to 975 000 shares at the public offering price.
The trading debut will tale place on the Nasdaq Global Select Market on April 30, 2021 under the ticker symbol “VACC”.